Institutional shares held 685,892
0 calls
0 puts
Total value of holdings $205K
$0 calls
$0 puts
Market Cap $273K
908,761 Shares Out.
Institutional ownership 75.48%
# of Institutions 19


Latest Institutional Activity in INM

Top Purchases

Q1 2024
Armistice Capital, LLC Shares Held: 267K ($80.1K)
Q1 2024
Two Sigma Securities, LLC Shares Held: 15.4K ($4.63K)
Q1 2024
Bfsg, LLC Shares Held: 200 ($60)
Q1 2024
Advisor Net Financial, Inc Shares Held: 80 ($24)
Q1 2024
Ubs Group Ag Shares Held: 41 ($12.3)

Top Sells

Q1 2024
Sabby Management, LLC Shares Held: 362K ($109K)
Q1 2024
Citadel Advisors LLC Shares Held: 12.7K ($3.82K)
Q1 2024
Renaissance Technologies LLC Shares Held: 28.3K ($8.49K)
Q1 2024
Td Waterhouse Canada Inc. Shares Held: 0 ($0)
Q4 2023
Bank Of America Corp Shares Held: 100 ($30)

About INM

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.


Insider Transactions at INM

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
79.1K Shares
From 2 Insiders
Open market or private purchase 79.1K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on INM

Follow InMed Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INM shares.

Notify only if

Insider Trading

Get notified when an In Med Pharmaceuticals Inc. insider buys or sells INM shares.

Notify only if

News

Receive news related to InMed Pharmaceuticals Inc.

Track Activities on INM